News coverage about Teleflex (NYSE:TFX) has trended somewhat positive this week, Accern reports. The research firm rates the sentiment of news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Teleflex earned a media sentiment score of 0.15 on Accern’s scale. Accern also gave news stories about the medical technology company an impact score of 46.3469498383479 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

These are some of the media headlines that may have impacted Accern Sentiment’s analysis:

Teleflex (TFX) traded up 2.82% during trading on Wednesday, hitting $214.79. 318,326 shares of the stock were exchanged. The stock has a market cap of $9.67 billion, a price-to-earnings ratio of 41.08 and a beta of 1.05. The firm’s 50 day moving average price is $209.53 and its 200-day moving average price is $198.00. Teleflex has a 1-year low of $136.53 and a 1-year high of $217.97.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.91 by $0.13. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. The business had revenue of $528.60 million during the quarter, compared to the consensus estimate of $518.98 million. During the same quarter last year, the firm posted $1.89 EPS. The company’s quarterly revenue was up 11.6% on a year-over-year basis. On average, analysts anticipate that Teleflex will post $8.28 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 15th. Shareholders of record on Tuesday, August 15th will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.63%. The ex-dividend date of this dividend is Friday, August 11th. Teleflex’s dividend payout ratio is 26.00%.

Several research firms recently commented on TFX. Needham & Company LLC restated a “buy” rating on shares of Teleflex in a report on Friday, August 4th. BidaskClub cut shares of Teleflex from a “hold” rating to a “sell” rating in a report on Tuesday, August 8th. Deutsche Bank AG restated a “buy” rating and set a $238.00 price target (up from $220.00) on shares of Teleflex in a report on Wednesday, August 9th. Jefferies Group LLC restated a “buy” rating and set a $253.00 price target (up from $230.00) on shares of Teleflex in a report on Wednesday, August 9th. Finally, Barclays PLC restated a “buy” rating on shares of Teleflex in a report on Monday, June 26th. One research analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock. Teleflex has a consensus rating of “Buy” and a consensus target price of $228.00.

COPYRIGHT VIOLATION NOTICE: This story was posted by Watch List News and is the property of of Watch List News. If you are reading this story on another website, it was illegally copied and republished in violation of US and international copyright and trademark laws. The original version of this story can be accessed at https://www.watchlistnews.com/teleflex-tfx-earning-somewhat-positive-media-coverage-report-shows/1496700.html.

In other Teleflex news, Director Stuart A. Randle sold 2,500 shares of the stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $205.67, for a total transaction of $514,175.00. Following the transaction, the director now owns 7,532 shares in the company, valued at approximately $1,549,106.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gretchen R. Haggerty acquired 1,000 shares of the stock in a transaction on Wednesday, June 21st. The shares were purchased at an average price of $203.82 per share, for a total transaction of $203,820.00. Following the transaction, the director now directly owns 1,760 shares in the company, valued at $358,723.20. The disclosure for this purchase can be found here. Insiders have sold a total of 3,100 shares of company stock worth $637,463 in the last quarter. Company insiders own 2.39% of the company’s stock.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Insider Buying and Selling by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.